Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

26.02
-0.2800-1.06%
Mar 21 13:28 EST
Volume:114.75K
Turnover:2.94M
Market Cap:715.57M
PE:-9.68
High:26.53
Open:25.81
Low:24.80
Close:26.30
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h

OnKure Therapeutics reports Q4 EPS ($1.37), consensus (86c)

TIPRANKS
·
11 Mar

Prescient Therapeutics Announces New Board Chair Amidst Growth Phase

TIPRANKS
·
11 Mar

Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges

TIPRANKS
·
11 Mar

Promising Clinical Developments and Strategic Advancements Support Buy Rating for Tenaya Therapeutics

TIPRANKS
·
10 Mar

Mineralys Therapeutics Launches $250 Million Public Offering of Shares

MT Newswires Live
·
10 Mar

Tenaya Therapeutics reports Q4 EPS (28c), consensus (31c)

TIPRANKS
·
10 Mar

Press Release: OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Dow Jones
·
10 Mar

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Business Wire
·
10 Mar

Press Release: Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
10 Mar

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
10 Mar

Beam Therapeutics Raised to Sector Outperform From Sector Perform by Scotiabank

Dow Jones
·
10 Mar

Checkpoint Therapeutics Cut to Hold From Buy by Lake Street

Dow Jones
·
10 Mar

Beam Therapeutics Raised to Buy From Hold by Jones Trading

Dow Jones
·
10 Mar

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

Benzinga
·
10 Mar

JonesResearch upgrades Beam Therapeutics to Buy on de-risking data

TIPRANKS
·
10 Mar

Beam Therapeutics upgraded to Buy from Hold at JonesResearch

TIPRANKS
·
10 Mar

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."